CytomX Therapeutics Inc (CTMX)
0.89
+0.02
(+2.71%)
USD |
NASDAQ |
Nov 22, 16:00
0.8913
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Total Assets (Quarterly): 138.98M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 138.98M |
| June 30, 2024 | 159.22M |
| March 31, 2024 | 184.69M |
| December 31, 2023 | 201.79M |
| September 30, 2023 | 221.17M |
| June 30, 2023 | 209.18M |
| March 31, 2023 | 234.63M |
| December 31, 2022 | 260.89M |
| September 30, 2022 | 226.49M |
| June 30, 2022 | 260.09M |
| March 31, 2022 | 296.82M |
| December 31, 2021 | 339.41M |
| September 30, 2021 | 371.23M |
| June 30, 2021 | 402.44M |
| March 31, 2021 | 434.16M |
| December 31, 2020 | 358.66M |
| September 30, 2020 | 375.18M |
| June 30, 2020 | 402.48M |
| March 31, 2020 | 436.66M |
| December 31, 2019 | 341.28M |
| Date | Value |
|---|---|
| September 30, 2019 | 372.54M |
| June 30, 2019 | 405.28M |
| March 31, 2019 | 444.51M |
| December 31, 2018 | 457.11M |
| September 30, 2018 | 482.73M |
| June 30, 2018 | 376.94M |
| March 31, 2018 | 376.46M |
| December 31, 2017 | 397.64M |
| September 30, 2017 | 387.04M |
| June 30, 2017 | 351.86M |
| March 31, 2017 | 177.88M |
| December 31, 2016 | 199.13M |
| September 30, 2016 | 192.88M |
| June 30, 2016 | 206.86M |
| March 31, 2016 | 191.95M |
| December 31, 2015 | 197.22M |
| September 30, 2015 | 124.78M |
| June 30, 2015 | 134.09M |
| December 31, 2014 | 73.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
138.98M
Minimum
Sep 2024
436.66M
Maximum
Mar 2020
292.77M
Average
278.86M
Median
Total Assets (Quarterly) Benchmarks
| Spero Therapeutics Inc | 135.16M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 162.43M |
| Shareholders Equity (Quarterly) | -23.45M |
| Current Ratio | 1.042 |